-
1
-
-
77955635233
-
Cancer statistics, 2010
-
Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin: 2010; 60 277 300
-
(2010)
CA Cancer J Clin
, vol.60
, pp. 277-300
-
-
Jemal, A.1
Siegel, R.2
Xu, J.3
Ward, E.4
-
2
-
-
77956616588
-
Pancreatic cancer stem cells - Update and future perspectives
-
Lonardo E, Hermann PC, Heeschen C. Pancreatic cancer stem cells - update and future perspectives. Mol Oncol: 2010; 4 431 442
-
(2010)
Mol Oncol
, vol.4
, pp. 431-442
-
-
Lonardo, E.1
Hermann, P.C.2
Heeschen, C.3
-
3
-
-
73949107880
-
Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment
-
Philip PA, Mooney M, Jaffe D, Eckhardt G, Moore M, Meropol N, Emens L, OReilly E, Korc M, Ellis L, Benedetti J, Rothenberg M, Willett C, Tempero M, Lowy A, Abbruzzese J, Simeone D, Hingorani S, Berlin J, Tepper J. Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment. J Clin Oncol: 2009; 27 5660 5669
-
(2009)
J Clin Oncol
, vol.27
, pp. 5660-5669
-
-
Philip, P.A.1
Mooney, M.2
Jaffe, D.3
Eckhardt, G.4
Moore, M.5
Meropol, N.6
Emens, L.7
Oreilly, E.8
Korc, M.9
Ellis, L.10
Benedetti, J.11
Rothenberg, M.12
Willett, C.13
Tempero, M.14
Lowy, A.15
Abbruzzese, J.16
Simeone, D.17
Hingorani, S.18
Berlin, J.19
Tepper, J.20
more..
-
4
-
-
34249933404
-
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada Clinical Trials Group
-
DOI 10.1200/JCO.2006.07.9525
-
Moore MJ, Goldstein D, Hamm J, Figer A, Hecht JR, Gallinger S, Au HJ, Murawa P, Walde D, Wolff RA, Campos D, Lim R, Ding K, Clark G, Voskoglou-Nomikos T, Ptasynski M, Parulekar W. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol: 2007; 25 1960 1966 (Pubitemid 46972777)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.15
, pp. 1960-1966
-
-
Moore, M.J.1
Goldstein, D.2
Hamm, J.3
Figer, A.4
Hecht, J.R.5
Gallinger, S.6
Au, H.J.7
Murawa, P.8
Walde, D.9
Wolff, R.A.10
Campos, D.11
Lim, R.12
Ding, K.13
Clark, G.14
Voskoglou-Nomikos, T.15
Ptasynski, M.16
Parulekar, W.17
-
5
-
-
0034327361
-
Remarkable tolerance of tumor cells to nutrient deprivation: Possible new biochemical target for cancer therapy
-
Izuishi K, Kato K, Ogura T, Kinoshita T, Esumi H. Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy. Cancer Res: 2000; 60 6201 6207
-
(2000)
Cancer Res
, vol.60
, pp. 6201-6207
-
-
Izuishi, K.1
Kato, K.2
Ogura, T.3
Kinoshita, T.4
Esumi, H.5
-
6
-
-
0037031895
-
Hypoxia and nitric oxide treatment confer tolerance to glucose starvation in a 5-AMP-activated protein kinase-dependent manner
-
DOI 10.1074/jbc.M112270200
-
Esumi H, Izuishi K, Kato K, Hashimoto K, Kurashima Y, Kishimoto A, Ogura T, Ozawa T. Hypoxia and nitric oxide treatment confer tolerance to glucose starvation in a 5-AMP-activated protein kinase-dependent manner. J Biol Chem: 2002; 277 32791 32798 (Pubitemid 34984788)
-
(2002)
Journal of Biological Chemistry
, vol.277
, Issue.36
, pp. 32791-32798
-
-
Esumi, H.1
Izuishi, K.2
Kato, K.3
Hashimoto, K.4
Kurashima, Y.5
Kishimoto, A.6
Ogura, T.7
Ozawa, T.8
-
7
-
-
3042642312
-
Kigamicin D, a novel anticancer agent based on a new anti-austerity strategy targeting cancer cells' tolerance to nutrient starvation
-
DOI 10.1111/j.1349-7006.2004.tb03247.x
-
Lu J, Kunimoto S, Yamazaki Y, Kaminishi M, Esumi H. Kigamicin D, a novel anticancer agent based on a new anti-austerity strategy targeting cancer cells tolerance to nutrient starvation. Cancer Sci: 2004; 95 547 552 (Pubitemid 38832706)
-
(2004)
Cancer Science
, vol.95
, Issue.6
, pp. 547-552
-
-
Lu, J.1
Kunimoto, S.2
Yamazaki, Y.3
Kaminishi, M.4
Esumi, H.5
-
8
-
-
32944457064
-
Identification of arctigenin as an antitumor agent having the ability to eliminate the tolerance of cancer cells to nutrient starvation
-
DOI 10.1158/0008-5472.CAN-05-3143
-
Awale S, Lu J, Kalauni SK, Kurashima Y, Tezuka Y, Kadota S, Esumi H. Identification of arctigenin as an antitumor agent having the ability to eliminate the tolerance of cancer cells to nutrient starvation. Cancer Res: 2006; 66 1751 1757 (Pubitemid 43259960)
-
(2006)
Cancer Research
, vol.66
, Issue.3
, pp. 1751-1757
-
-
Awale, S.1
Lu, J.2
Kalauni, S.K.3
Kurashima, Y.4
Tezuka, Y.5
Kadota, S.6
Esumi, H.7
-
9
-
-
79955011090
-
Targeting the resistance of pancreatic cancer cells to nutrient deprivation: Anti-austerity compounds
-
Magolan J, Coster MJ. Targeting the resistance of pancreatic cancer cells to nutrient deprivation: anti-austerity compounds. Curr Drug Deliv: 2010; 7 355 369
-
(2010)
Curr Drug Deliv
, vol.7
, pp. 355-369
-
-
Magolan, J.1
Coster, M.J.2
-
10
-
-
33751032619
-
Diterpenes from "Pini Resina" and their preferential cytotoxic activity under nutrient-deprived condition
-
DOI 10.1055/s-2006-947189
-
Zaidi SF, Awale S, Kalauni SK, Tezuka Y, Esumi H, Kadota S. Diterpenes from "Pini Resinao" and their preferential cytotoxic activity under nutrient-deprived condition. Planta Med: 2006; 72 1231 1234 (Pubitemid 44759234)
-
(2006)
Planta Medica
, vol.72
, Issue.13
, pp. 1231-1234
-
-
Zaidi, S.F.H.1
Awale, S.2
Kalauni, S.K.3
Tezuka, Y.4
Esumi, H.5
Kadota, S.6
-
11
-
-
29544446440
-
Angelmarin, a novel anti-cancer agent able to eliminate the tolerance of cancer cells to nutrient starvation
-
DOI 10.1016/j.bmcl.2005.10.046, PII S0960894X0501334X
-
Awale S, Nakashima EM, Kalauni SK, Tezuka Y, Kurashima Y, Lu J, Esumi H, Kadota S. Angelmarin, a novel anti-cancer agent able to eliminate the tolerance of cancer cells to nutrient starvation. Bioorg Med Chem Lett: 2006; 16 581 583 (Pubitemid 43014840)
-
(2006)
Bioorganic and Medicinal Chemistry Letters
, vol.16
, Issue.3
, pp. 581-583
-
-
Awale, S.1
Nakashima, E.M.N.2
Kalauni, S.K.3
Tezuka, Y.4
Kurashima, Y.5
Lu, J.6
Esumi, H.7
Kadota, S.8
-
12
-
-
36349033961
-
Bioactive secondary metabolites from Boesenbergia pandurata of Myanmar and their preferential cytotoxicity against human pancreatic cancer PANC-1 cell line in nutrient-deprived medium
-
DOI 10.1021/np070286m
-
Win NN, Awale S, Esumi H, Tezuka Y, Kadota S. Bioactive secondary metabolites from Boesenbergia pandurata of Myanmar and their preferential cytotoxicity against human pancreatic cancer PANC-1 cell line in nutrient-deprived medium. J Nat Prod: 2007; 70 1582 1587 (Pubitemid 350155407)
-
(2007)
Journal of Natural Products
, vol.70
, Issue.10
, pp. 1582-1587
-
-
Nwet, N.W.1
Awale, S.2
Esumi, H.3
Tezuka, Y.4
Kadota, S.5
-
13
-
-
51349169728
-
Novel anticancer agents, kayeassamins C-I from the flower of Kayea assamica of Myanmar
-
Win NN, Awale S, Esumi H, Tezuka Y, Kadota S. Novel anticancer agents, kayeassamins C-I from the flower of Kayea assamica of Myanmar. Bioorg Med Chem: 2008; 16 8653 8660
-
(2008)
Bioorg Med Chem
, vol.16
, pp. 8653-8660
-
-
Win, N.N.1
Awale, S.2
Esumi, H.3
Tezuka, Y.4
Kadota, S.5
-
14
-
-
38049034385
-
Constituents of Brazilian red propolis and their preferential cytotoxic activity against human pancreatic PANC-1 cancer cell line in nutrient-deprived condition
-
Awale S, Li F, Onozuka H, Esumi H, Tezuka Y, Kadota S. Constituents of Brazilian red propolis and their preferential cytotoxic activity against human pancreatic PANC-1 cancer cell line in nutrient-deprived condition. Bioorg Med Chem: 2008; 16 181 189
-
(2008)
Bioorg Med Chem
, vol.16
, pp. 181-189
-
-
Awale, S.1
Li, F.2
Onozuka, H.3
Esumi, H.4
Tezuka, Y.5
Kadota, S.6
-
15
-
-
48649110502
-
Novel anticancer agents, kayeassamins A and B from the flower of Kayea assamica of Myanmar
-
Win NN, Awale S, Esumi H, Tezuka Y, Kadota S. Novel anticancer agents, kayeassamins A and B from the flower of Kayea assamica of Myanmar. Bioorg Med Chem Lett: 2008; 18 4688 4691
-
(2008)
Bioorg Med Chem Lett
, vol.18
, pp. 4688-4691
-
-
Win, N.N.1
Awale, S.2
Esumi, H.3
Tezuka, Y.4
Kadota, S.5
-
16
-
-
68049114757
-
Chemical constituents of propolis from Myanmar and their preferential cytotoxicity against a human pancreatic cancer cell line
-
Li F, Awale S, Zhang H, Tezuka Y, Esumi H, Kadota S. Chemical constituents of propolis from Myanmar and their preferential cytotoxicity against a human pancreatic cancer cell line. J Nat Prod: 2009; 72 1283 1287
-
(2009)
J Nat Prod
, vol.72
, pp. 1283-1287
-
-
Li, F.1
Awale, S.2
Zhang, H.3
Tezuka, Y.4
Esumi, H.5
Kadota, S.6
-
17
-
-
77951523025
-
Study on the constituents of Mexican propolis and their cytotoxic activity against PANC-1 human pancreatic cancer cells
-
Li F, Awale S, Tezuka Y, Esumi H, Kadota S. Study on the constituents of Mexican propolis and their cytotoxic activity against PANC-1 human pancreatic cancer cells. J Nat Prod: 2010; 73 623 627
-
(2010)
J Nat Prod
, vol.73
, pp. 623-627
-
-
Li, F.1
Awale, S.2
Tezuka, Y.3
Esumi, H.4
Kadota, S.5
-
18
-
-
33846417209
-
-
Chinese Pharmacopoeia Commission Beijing Chemical Industry Press
-
Chinese Pharmacopoeia Commission Pharmacopoeia of the Peoples Republic of China. Beijing Chemical Industry Press: 2005
-
(2005)
Pharmacopoeia of the Peoples Republic of China
-
-
-
19
-
-
34447092603
-
Quality assessment of Rhizoma et Radix Notopterygii by HPTLC and HPLC fingerprinting and HPLC quantitative analysis
-
DOI 10.1016/j.jpba.2007.03.029, PII S0731708507001902
-
Qian GS, Wang Q, Leung KS, Qin Y, Zhao Z, Jiang ZH. Quality assessment of Rhizoma et Radix Notopterygii by HPTLC and HPLC fingerprinting and HPLC quantitative analysis. J Pharm Biomed Anal: 2007; 44 812 817 (Pubitemid 47030776)
-
(2007)
Journal of Pharmaceutical and Biomedical Analysis
, vol.44
, Issue.SPEC. ISS. 3
, pp. 812-817
-
-
Qian, G.-S.1
Wang, Q.2
Leung, K.S.-Y.3
Qin, Y.4
Zhao, Z.5
Jiang, Z.-H.6
-
20
-
-
0030753021
-
5-Lipoxygenase and cyclooxygenase inhibitory active constituents from Qianghuo (Notopterygium incisum)
-
DOI 10.1055/s-2006-957653
-
Zschocke S, Lehner M, Bauer R. 5-Lipoxygenase and cyclooxygenase inhibitory active constituents from Qianghuo (Notopterygium incisum). Planta Med: 1997; 63 203 206 (Pubitemid 27287058)
-
(1997)
Planta Medica
, vol.63
, Issue.3
, pp. 203-206
-
-
Zschocke, S.1
Lehner, M.2
Bauer, R.3
-
21
-
-
0026053011
-
Comparison of anti-lipid peroxidative effects of the underground parts of Notopterygium incisum and N. forbesii in mice
-
Yang XW, Gu ZM, Wang BX, Hattori M, Namba T. Comparison of anti-lipid peroxidative effects of the underground parts of Notopterygium incisum and N. forbesii in mice. Planta Med: 1991; 57 399 402
-
(1991)
Planta Med
, vol.57
, pp. 399-402
-
-
Yang, X.W.1
Gu, Z.M.2
Wang, B.X.3
Hattori, M.4
Namba, T.5
-
22
-
-
0027214107
-
Analgesic component of Notopterygium incisum Ting
-
Okuyama E, Nishimura S, Ohmori S, Ozaki Y, Satake M, Yamazaki M. Analgesic component of Notopterygium incisum Ting. Chem Pharm Bull (Tokyo): 1993; 41 926 929 (Pubitemid 23240056)
-
(1993)
Chemical and Pharmaceutical Bulletin
, vol.41
, Issue.5
, pp. 926-929
-
-
Okuyama, E.1
Nishimura, S.2
Ohmori, S.3
Ozaki, Y.4
Satake, M.5
Yamazaki, M.6
-
23
-
-
33646482930
-
Anti-influenza agents from plants and traditional Chinese medicine
-
Wang X, Jia W, Zhao A. Anti-influenza agents from plants and traditional Chinese medicine. Phytother Res: 2006; 20 335 341
-
(2006)
Phytother Res
, vol.20
, pp. 335-341
-
-
Wang, X.1
Jia, W.2
Zhao, A.3
-
24
-
-
0033173688
-
Differentiation in a rat PC12 cell line induced by ostruthin and (-)-bornyl ferulate, constituents of a Chinese herbal medicine
-
Qi J, Ojika M, Sakagami Y. Differentiation in a rat PC12 cell line induced by ostruthin and ()-bornyl ferulate, constituents of a Chinese herbal medicine. Biosci Biotechnol Biochem: 1999; 63 1501 1502 (Pubitemid 129549171)
-
(1999)
Bioscience, Biotechnology and Biochemistry
, vol.63
, Issue.8
, pp. 1501-1502
-
-
Qi, J.1
Ojika, M.2
Sakagami, Y.3
-
25
-
-
74549154533
-
Antiproliferative and apoptotic activities of linear furocoumarins from Notopterygium incisum on cancer cell lines
-
Wu SB, Pang F, Wen Y, Zhang HF, Zhao Z, Hu JF. Antiproliferative and apoptotic activities of linear furocoumarins from Notopterygium incisum on cancer cell lines. Planta Med: 2010; 76 82 85
-
(2010)
Planta Med
, vol.76
, pp. 82-85
-
-
Wu, S.B.1
Pang, F.2
Wen, Y.3
Zhang, H.F.4
Zhao, Z.5
Hu, J.F.6
|